{"nctId":"NCT00933933","briefTitle":"Evaluation of Diagnostic HIV Ag/Ab Combo Assay","startDateStruct":{"date":"2009-06"},"conditions":["Human Immunodeficiency Viruses"],"count":635,"armGroups":[{"label":"ARCHITECT HIV Ag/Ab Combo Specificity","type":"EXPERIMENTAL","interventionNames":["Device: ARCHITECT HIV Ag/Ab Combo"]},{"label":"ARCHITECT HIV Ag/Ab Combo Sensitivity","type":"NO_INTERVENTION","interventionNames":[]},{"label":"ARCHITECT HIV Ag/Ab Combo Reactivity","type":"EXPERIMENTAL","interventionNames":["Device: ARCHITECT HIV Ag/Ab Combo"]}],"interventions":[{"name":"ARCHITECT HIV Ag/Ab Combo","otherNames":[]},{"name":"ARCHITECT HIV Ag/Ab Combo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Normal Healthy Population:\n\nInclusion Criteria:\n\n* Apparently healthy individual at the time of enrollment as affirmed by the subject\n\nExclusion Criteria:\n\n* HIV infection as affirmed by the subject\n\nPregnant Female Population at Risk for HIV Infection:\n\nInclusion Criteria:\n\n* Subject is a pregnant female\n* Subject has risk factor for HIV infection\n\nExclusion Criteria:\n\n* HIV infection as affirmed by the subject\n\nHIV-1 Positive Pregnant Female Subjects\n\nInclusion Criteria:\n\n* Subject is a pregnant female in first, second, or third trimester\n* Subject must have documented HIV infection\n\nExclusion Criteria:\n\n* None\n\nHIV-1 Positive Pediatric Subjects\n\nInclusion Criteria:\n\n* Subject must be 2 years to 16 years of age\n* Subject must have documented HIV infection (e.g., Western blot positive or HIV RNA positive/detectable)\n\nExclusion Criteria:\n\n* None","healthyVolunteers":true,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Architect HIV Combo Test Data for Clinical Specificity in Population at Low Risk for HIV Infection","description":"HIV status was determined by the results of the HIV comparator assay, HIV-1 Western blot, HIV-2 Western blot, and HIV-1 ribonucleic acid (RNA) test.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6113","spread":null}]}]}]},{"type":"PRIMARY","title":"Architect HIV Combo Test Data for Clinical Sensitivity in HIV Positive Specimens","description":"Positive HIV status was determined by the results of the HIV-1 Western blot, HIV-2 Western blot, and/or HIV-1 ribonucleic acid (RNA) test.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63","spread":null},{"groupId":"OG001","value":"1003","spread":null},{"groupId":"OG002","value":"201","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Architect HIV Combo Test Data for Specificity and Sensitivity in Pregnant Female Population","description":"HIV status was determined by the results of the HIV comparator assay, HIV-1 Western blot, HIV-2 Western blot, and HIV-1 ribonucleic acid (RNA) test.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"448","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Architect HIV Combo Test Data for Specificity and Sensitivity in Pediatric Population (From 2 up to 21 Years of Age)","description":"HIV status was determined by the results of the HIV comparator assay, HIV-1 Western blot, HIV-2 Western blot, and HIV-1 ribonucleic acid (RNA) test.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"587","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Architect HIV Combo Test Data for Reactivity of Architect HIV Combo in Increased HIV Risk Populations","description":"Reactivity was determined by the results of the Architect HIV Ag/Ab Combo assay and supplemental testing by HIV-1 Western blot, HIV-2 Western blot, and HIV-1 ribonucleic acid (RNA) test.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"83","spread":null},{"groupId":"OG002","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"622","spread":null},{"groupId":"OG001","value":"424","spread":null},{"groupId":"OG002","value":"198","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":586},"commonTop":[]}}}